Month: March 2021

A new study illuminates the complex array of neurological issues experienced by people months after their coronavirus infections. View original article Contributor: Pam Belluck

Medical schools and students alike have had to adapt to remote cadaver dissections and bedside-manner training via Zoom. View original article Contributor: Emma Goldberg

AstraZeneca announced the long-awaited results of the U.S. and South American study of its COVID-19 vaccine, and it was the first bit of positive news about the shot in recent weeks, after a parade of countries halted its use due to reports of blood clot complications. In the Phase 3 study involving more than 32,000 … Read more

Plenty of drama in Europe this past week as the AstraZeneca vaccine—a crucial component of the continent’s vaccination plans—was paused by more than a dozen European countries after a few reports emerged of blood clots in people after receiving the vaccine. Europe’s FDA equivalent, the European Medicines Agency (EMA), says that it is still “safe … Read more

LONDON — AstraZeneca says advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announced Monday. The early findings from the U.S. study are just one set … Read more

Indoor fitness classes, which often result in heavy breathing in poorly ventilated rooms, can be risky. Here’s a guide to help you decide if your gym is doing enough to prevent the spread of Covid-19. View original article Contributor: Tara Parker-Pope and Gretchen Reynolds

Millions of older Americans, chronically ill and trapped at home, pose a big challenge to inoculation efforts. Doctors are on it. View original article Contributor: Roni Caryn Rabin and Chang W. Lee